BioLargo Income After Taxes 2010-2024 | BLGO
BioLargo income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
BioLargo Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-5 |
| 2022 |
$-5 |
| 2021 |
$-7 |
| 2020 |
$-10 |
| 2019 |
$-11 |
| 2018 |
$-11 |
| 2017 |
$-10 |
| 2016 |
$-8 |
| 2015 |
$-5 |
| 2014 |
$-4 |
| 2013 |
$-3 |
| 2012 |
$-5 |
| 2011 |
$-4 |
| 2010 |
$-6 |
| 2009 |
$-16 |
BioLargo Quarterly Income After Taxes
(Millions of US $) |
| 2024-09-30 |
$-1 |
| 2024-06-30 |
$-1 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-1 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$-0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-1 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-2 |
| 2021-12-31 |
$-2 |
| 2021-09-30 |
$-1 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-3 |
| 2020-03-31 |
$-3 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$-4 |
| 2019-06-30 |
$-2 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-2 |
| 2018-09-30 |
$-2 |
| 2018-06-30 |
$-4 |
| 2018-03-31 |
$-2 |
| 2017-12-31 |
$-2 |
| 2017-09-30 |
$-2 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-2 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$-2 |
| 2015-12-31 |
$-1 |
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-1 |
| 2015-03-31 |
$-1 |
| 2014-12-31 |
$-1 |
| 2014-09-30 |
$-1 |
| 2014-06-30 |
$-1 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$-1 |
| 2013-09-30 |
$-1 |
| 2013-06-30 |
$-1 |
| 2013-03-31 |
$-1 |
| 2012-12-31 |
$-2 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-2 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-1 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-2 |
| 2009-12-31 |
$-10 |
| 2009-09-30 |
$-2 |
| 2009-06-30 |
$-2 |
| 2009-03-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.087B |
$0.012B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
